advertisement

The 5 Most Hated Biotechs: Myriad, Sarepta, OncoMed, VIVUS, and MannKind

33 %
67 %
advertisement
Information about The 5 Most Hated Biotechs: Myriad, Sarepta, OncoMed, VIVUS, and MannKind
Investor Relations

Published on March 13, 2014

Author: TheMotleyFool

Source: slideshare.net

Description

The five companies with the largest number of shares sold short as a percentage of float.
advertisement

Add a comment

Related presentations

Gage-Cannon Investor Services

Gage-Cannon Investor Services

November 10, 2014

Gage-Cannon helps ventures accelerate organic growth or obtain equity funding, and...

Mavenir Analyst Day

Foro MAB Sevilla 13 de noviembre de 2014

ING Q3 2014 Earnings Report

ING Q3 2014 Earnings Report

November 5, 2014

Analyst presentation third quarter 2014 results. ING posts 3Q14 underlying net pro...

Related pages

The 5 Most Hated Biotechs: Myriad, Sarepta, OncoMed, VIVUS ...

The 5 Most Hated Biotechs: Myriad, Sarepta, OncoMed, ... OMED ) , VIVUS (NASDAQ: VVUS ) , and MannKind (NASDAQ: ... 5.74 0.03% S&P 500: 2,083.39 ...
Read more

The 5 Most Hated Biotechs: Myraid, Sarepta, Questcor ...

... and MannKind top the list of the most shorted biotechs. ... The 5 Most Hated Biotechs: Myraid, Sarepta, Questcor, ... not to Myriad Genetics)
Read more

Myriad | LinkedIn

View 114605 Myriad posts, presentations, experts, and more. Get the professional knowledge you need on LinkedIn. LinkedIn Home What is LinkedIn? Join Today
Read more

OncoMed | Cafepharma

The 5 Most Hated Biotechs: Myriad, Sarepta, OncoMed, VIVUS, and MannKind. The 5 Most Hated Biotechs: Myriad, Sarepta, OncoMed, VIVUS, ... Vivus. MannKind ...
Read more

3 bursting biotech stocks -- 1 to buy

1. 3 Bursting Biotech Stocks – 1 to Buy Source: Achillion Pharma 2. 1. Zafgen, Inc. (NASDAQ: ZFGN) Zafgen, Inc. is a clinical stage biotechnology company ...
Read more

What You Need to Know About iPhone 6

Leaked! Everything You Need To Know About the Upcoming iPhone 6 All Your iPhone 6 News in One Place • In the following slideshow, we have collected all ...
Read more

Vivus News & Analysen | finanzen.at

Vivus News & Analysen: Hier finden Sie die News & Analysen-Seite für den Wert Vivus. Benutzername (E-Mail) Passwort. Registrieren? Fan werden; finanzen.at ...
Read more

Adam Feuerstein's Biotech Blog - TheStreet

To participate in Adam's "Biotech Stock Mailbag," please send your ... the most closely followed biotech sector ... MannKind's inhaled ...
Read more